Sei Investments Co. Purchases 148,493 Shares of GE HealthCare Technologies Inc. $GEHC

Sei Investments Co. grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.8% during the first quarter, Holdings Channel reports. The fund owned 435,043 shares of the company’s stock after purchasing an additional 148,493 shares during the period. Sei Investments Co.’s holdings in GE HealthCare Technologies were worth $30,965,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. State of Wyoming boosted its position in shares of GE HealthCare Technologies by 215.1% during the first quarter. State of Wyoming now owns 1,314 shares of the company’s stock valued at $94,000 after purchasing an additional 897 shares in the last quarter. Cetera Investment Advisers lifted its position in GE HealthCare Technologies by 0.5% during the first quarter. Cetera Investment Advisers now owns 85,908 shares of the company’s stock valued at $6,115,000 after buying an additional 427 shares during the period. Mizuho Markets Cayman LP lifted its position in GE HealthCare Technologies by 173.2% during the first quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company’s stock valued at $218,416,000 after buying an additional 1,945,500 shares during the period. First Citizens Bank & Trust Co. boosted its holdings in shares of GE HealthCare Technologies by 2.4% during the 1st quarter. First Citizens Bank & Trust Co. now owns 28,879 shares of the company’s stock valued at $2,056,000 after buying an additional 674 shares in the last quarter. Finally, Saturna Capital Corp bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $616,000. Institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on GEHC. Oppenheimer reiterated an “outperform” rating and issued a $85.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. BNP Paribas Exane dropped their price objective on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Zacks Research cut shares of GE HealthCare Technologies from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 21st. Mizuho decreased their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Finally, Weiss Ratings lowered shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. Ten equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Hold” and a consensus price target of $76.41.

Insider Activity

In related news, CFO James Saccaro purchased 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The stock was purchased at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the purchase, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. The trade was a 3.93% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Peter J. Arduini acquired 4,169 shares of the firm’s stock in a transaction dated Thursday, April 30th. The shares were bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have bought 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $61.12 on Tuesday. The company has a market cap of $27.80 billion, a price-to-earnings ratio of 14.62, a P/E/G ratio of 1.65 and a beta of 0.72. The business’s fifty day simple moving average is $63.63 and its two-hundred day simple moving average is $70.96. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the prior year, the firm earned $1.01 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.35%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.